Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients & plaques at a significantly higher risk for subsequent MACE. View now View Now

Reduce blood loss with the OKAY II Y-Connector Set

#1 selling Y-Connector in Japan.
Now available in the US.
View Product Details

Logo

Now FDA indicated to identify plaque and patients at increased risk of MACE.

Achieve unparalleled insights with the Makoto™ Imaging System and its accompanying Dualpro™ IVUS + NIRS catheter, the only FDA-cleared dual-modality catheter and imaging system indicated for the identification of patients and plaques at increased risk of major adverse cardiac events (MACE).

Explore the

LRP STUDY RESULTS

 

See the Makoto™

SYSTEM IN ACTION

 

Discover the

IVUS+NIRS TECHNOLOGY

 

Global Products

In 2015, Nipro Corporation acquired lnfraredx, a U.S. Imaging Company, as part of its long-term strategic plan to build a world class cardiovascular brand.

LEARN MORE ABOUT NIPRO

LRP: Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients

We are Pioneers

developing solutions aimed at conquering vascular disease

SEE WHAT IT TAKES

© 2019 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative